Search Results - "Escuín, F"

Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study by Morales, Jose Maria, Marcén, Roberto, del Castillo, Domingo, Andres, Amado, Gonzalez-Molina, Miguel, Oppenheimer, Federico, Serón, Daniel, Gil-Vernet, Salvador, Lampreave, Ildefonso, Gainza, Francisco Javier, Valdés, Francisco, Cabello, Mercedes, Anaya, Fernando, Escuin, Fernando, Arias, Manuel, Pallardó, Luis, Bustamante, Jesus

“…To describe the causes of graft loss, patient death and survival figures in kidney transplant patients in Spain based on the recipient's age. The results at 5…”
Get full text

Intravenous immunoglobulin: another therapeutic application by de Gracia, R, Jiménez, C, Gil, F, Escuín, F, Castell, J, Sanz, A

“…Intravenous immunoglobulin (IVIG) has immunoregulatory functions. In renal transplant, IVIG has been used as an immunosupressor agent only during short period…”
Get full text

The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure by Morales, J. M., Domínguez-Gil, B., Sanz-Guajardo, D., Fernández, J., Escuin, F.

“…Background. Chronic liver disease is one of the most important complications after renal transplantation. Hepatitis B and mainly hepatitis C are the more…”
Get full text

Sublingual administration of tacrolimus in a renal transplant patient by Romero, I., Jiménez, C., Gil, F., Escuin, F., Ramirez, E., Fudio, S., Borobia, A., Carcas, A.

“…Summary Tacrolimus is used in renal and other organ transplantations for immunossupression therapy. Bioavailability of enterally administered tacrolimus is…”
Get full text

Renal Function in Patients With Cadaveric Kidney Transplants Treated With Tacrolimus or Cyclosporine by Gonzalez Molina, M, Morales, J.M, Marcen, R, Campistol, J.M, Oppenheimer, F, Serón, D, Gil-Vernet, S, Capdevila, L, Andrés, A, Lampreave, I, Del Castillo, D, Cabello, M, Burgos, D, Valdés, F, Anaya, F, Escuín, F, Arias, M, Pallardó, L, Bustamante, J

“…Abstract Introduction Renal function predicts graft survival in kidney transplant patients. This study compared the 2-year evolution of renal function in…”
Get full text

Prophylaxis and Treatment of Cytomegalovirus Infection Postrenal Transplantation in Two Madrid Units by Fernández, A, Amezquita, Y, Fernández-Tagarro, E, Escuin, F, Jiménez, C, Sánchez Villanueva, R, Galeano, C, Pascual, J, Marcén, R

“…Abstract Introduction Complete prevention of cytomegalovirus (CMV) disease continues to be an unresolved problem in renal transplantation. Materials and…”
Get full text

Posttransplant Diabetes Mellitus in Renal Allograft Recipients: A Prospective Multicenter Study at 2 Years by Marcén, R., Morales, J.M., del Castillo, D., Campistol, J.M., Serón, D., Valdés, F., Anaya, F., Andrés, A., Arias, M., Bustamante, J., Capdevila, L., Escuin, F., Gil-Vernet, S., Gonzalez-Molina, M., Lampreave, I., Oppenheimer, F., Pallardó, L.

“…The purpose of this study was to investigate the incidence and risk factors for the development of diabetes mellitus after kidney transplantation (PTDM). A…”
Get full text

A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function by Andrés, Amado, Marcén, Roberto, Valdés, Francisco, Sánchez Plumed, Jaime, Solà, Ricard, Errasti, Pedro, Lauzurica, Ricardo, Pallardó, Luis, Bustamante, Jesús, Amenábar, Juan José, Plaza, Juan José, Gómez, Ernesto, Grinyó, Josep Maria, Rengel, Manuel, Puig, Josep Maria, Sanz, Aurelio, Asensio, Concepción, Andrés, Inés

“…:  This study assays therapy with basiliximab and different patterns of cyclosporin A (CsA) initiation in renal transplant (RT) recipients from expanded…”
Get full text

Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation by ROSTAING, Lionel, CANTAROVICH, Diego, ORTUNO-MIRETE, Joaquin, CHARPENTIER, Bernard, LEGENDRE, Christophe, SANCHEZ-PLUMED, Jaime, OPPENHEIMER, Federico, KESSLER, Michele, MOURAD, Georges, BUDDE, Klemens, RIGOTTI, Paolo, MARIAT, Christophe, MARGREITER, Raimund, CAPDEVILLA, Luis, LANG, Phillippe, VIALTEL, Paul

“…Corticosteroid-free maintenance immunosuppression after organ transplantation eliminates the well-known corticosteroid-related side effects and may help to…”
Get full text

Calcineurin-inhibitor-free immunosuppression in early renal transplantation by Olea, T, Jiménez, C, Escuín, F, García de Miguel, A, Ros, S, Sanz, A

“…Calcineurin inhibitors are one of the most common drugs used for prevention of acute rejection in recipients of renal allografts. New immunosuppressors have…”
Get full text

A comparative survey on the incidence of kidney graft primary vascular thrombosis among CAPD and haemodialysis patients by Escuin, F, Del Peso, G, Pérez Fontán, M, Rodriguez-Carmona, A, Martínez, A, Lanuza, M, Hortal, L, Fernández, A M, Albero, M D, Pérez Contreras, J, Selgas, R

Get full text

Renal Function at Six Months Is the Most Relevant Risk Factor for Graft Failure at Seven Years after Renal Transplantation: 1919 by Morales, J. M., Marcen, R., Andres, A., Anaya, F., Arias, M., Bustamante, J., Del Castillo, D., Cabello, M., Escuin, F., Gainza, F. J., Gil-Vernet, S., Lampreabe, I., Oppenheimer, F., Pallardo, L., Seron, D., Valdes, F.

Get full text

Pretransplant Diabetes Mellitus Doubles the Risk of Cardiovascular Events after Renal Transplantation. A Prospective Multicenter Study: 2378 by Morales, J. M., Marcen, R., Andres, A., Anaya, F., Arias, M., Bustamante, J., del Castillo, D., Cabello, M., Escuin, F., Gaínza, F. J., Gil-Vernet, S., Oppenheimer, F., Pallardo, L., Seron, D., Valdes, F.

Get full text

Acute renal failure caused by cholesterol embolism in kidney transplantation from cadaver donor. Is the prognosis more favorable than in native kidneys? by Díaz, C, Escuín, F, Jiménez, C, Picazo, M L, Gil, F, Costero, O, Sanz-Guajardo, A

“…We present the case of a 47 years old women with a third cadaveric kidney transplant. After surgery, she had effective diuresis reaching a serum creatinine of…”
Get full text

Mycobacterium chelonei peritonitis due to hematogenous dissemination in a continuous ambulatory peritoneal dialysis patient by Selgas, R, Muñoz, J, Aquella, A, Huarte, E, Fonseca, E, Escuin, F, Contreras, F

“…Renal failure patients have been found to have a special susceptibility to Mycobacterium infections. In patients undergoing peritoneal dialysis, Mycobacterium…”
Get more information

Prevention of cardiovascular risk in renal transplantation. Consensus document by Morales, J M, González Molina, M, Campistol, J M, del Castillo, D, Anaya, F, Oppenheimer, F, Gil Vernet, J M, Grinyo, J M, Capdevila, L, Lampreave, I, Valdés, F, Marcén, R, Escuín, F, Andrés, A, Arias, M, Pallardó, L

Get full text

Angiomyelolipoma associated with bilateral adrenocortical hyperplasia and hypertension by Escuin, F, Gomez, P, Martinez, I, Pérez-Fontan, M, Selgas, R, Sanchez-Sicilia, L

“…We report a case of adrenal myelolipoma associated with adrenocortical hyperplasia and hypertension. Although several endocrine derangements have been…”
Get more information

Peritoneal functional parameters after five years on continuous ambulatory peritoneal dialysis (CAPD): the effect of late peritonitis by Selgas, R, Muñoz, J, Cigarran, S, Ramos, P, L-Revuelta, K, Escuin, F, Miguel, J L

“…Functional stability of the peritoneum is essential for patients on long-term continuous ambulatory peritoneal dialysis (CAPD) treatment. Sixteen patients on…”
Get more information

Sublingual administration of tacrolimus in a renal transplant patient: Efficacy and safety of tacrolimus administration by Romero, I., Jiménez, C., Gil, F., Escuin, F., Ramirez, E., Fudio, S., Borobia, A., Carcas, A.

Get full text

Hemolytic uremic syndrome in a patient with gastric adenocarcinoma: partial recovery of renal function after gastrectomy by Ortega Marcos, O, Escuin, F, Miguel, J L, Gómez Fernández, P, Pérez Fontán, M, Selgas, R, Sanchez Sicilia, L

“…We report on a patient with gastric adenocarcinoma and severe renal failure caused by hemolytic uremic syndrome with predominantly vascular involvement…”
Get more information